A patient with newly diagnosed breast cancer found to have mosaic
                    <i>TP53</i>
                    likely pathogenic variant

Hetal D. Mistry; MacKenzie R. Adams; Charu Taneja; Lauren J. Massingham; Elizabeth H. Dibble; Kara L. Leonard; Jesse Hart; Galina G. Lagos; Mary Anne Fenton

doi:10.3322/caac.70034

A patient with newly diagnosed breast cancer found to have mosaic <i>TP53</i> likely pathogenic variant

H Hetal D. Mistry (Department of Hematology/Oncology Brown University Health Cancer Institute Providence Rhode Island USA) M MacKenzie R. Adams (Warren Alpert School of Medicine Brown University Providence Rhode Island USA) C Charu Taneja (Warren Alpert School of Medicine Brown University Providence Rhode Island USA) L Lauren J. Massingham (Department of Hematology/Oncology Brown University Health Cancer Institute Providence Rhode Island USA) E Elizabeth H. Dibble (Warren Alpert School of Medicine Brown University Providence Rhode Island USA) K Kara L. Leonard (Department of Radiation Oncology Brown University Health Warren Alpert Medical School of Brown University Providence Rhode Island USA) J Jesse Hart (Department of Pathology and Laboratory Medicine Brown University Health Rhode Island Hospital Warren Alpert School of Medicine Brown University Providence Rhode Island USA) G Galina G. Lagos (Department of Hematology/Oncology Brown University Health Cancer Institute Providence Rhode Island USA) M Mary Anne Fenton (Department of Hematology/Oncology Brown University Health Cancer Institute Providence Rhode Island USA)

Download PDF View Original

APA MLA Chicago BibTeX RIS

Article Details

Journal CA: A Cancer Journal for Clinicians

Volume / Issue Vol. 76, Issue 1

Published January 01, 2026

DOI 10.3322/caac.70034

ISSN 0007-9235

Publisher Wiley

Journal Info

CA: A Cancer Journal for Clinicians

Wiley

ISSN: 0007-9235 Open Access Q1 Medicine

Authors (9)

H

Hetal D. Mistry

Department of Hematology/Oncology Brown University Health Cancer Institute Providence Rhode Island USA

M

MacKenzie R. Adams

Warren Alpert School of Medicine Brown University Providence Rhode Island USA

C

Charu Taneja

Warren Alpert School of Medicine Brown University Providence Rhode Island USA

L

Lauren J. Massingham

Department of Hematology/Oncology Brown University Health Cancer Institute Providence Rhode Island USA

E

Elizabeth H. Dibble

Warren Alpert School of Medicine Brown University Providence Rhode Island USA

K

Kara L. Leonard

Department of Radiation Oncology Brown University Health Warren Alpert Medical School of Brown University Providence Rhode Island USA

J

Jesse Hart

Department of Pathology and Laboratory Medicine Brown University Health Rhode Island Hospital Warren Alpert School of Medicine Brown University Providence Rhode Island USA

G

Galina G. Lagos

Department of Hematology/Oncology Brown University Health Cancer Institute Providence Rhode Island USA

M

Mary Anne Fenton

Department of Hematology/Oncology Brown University Health Cancer Institute Providence Rhode Island USA

A patient with newly diagnosed breast cancer found to have mosaic <i>TP53</i> likely pathogenic variant

Article Details

Journal Info

Authors (9)

Related Articles from this Journal

Systemic amyloid light‐chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates

Screening for colorectal cancer

Correction to “Integrating multimodal management and molecular profiling in a patient with BRAF V600E–positive melanoma and brain metastases”

Blood tests for colorectal cancer—Hype ahead of evidence?

Medullary thyroid carcinoma and <i>RET</i> molecular testing: A virtual tumor board on clinical decision‐making